Stefan Galander

Stefan Galander is an Investment Associate at Cambridge Enterprise, where he specializes in early-stage life sciences investments and venture creation. In this capacity, he is responsible for identifying, developing, and funding innovative startup companies that emerge directly from academic research conducted at the University of Cambridge. Prior to his current position, Galander served as an Associate at Sana Capital, where he evaluated emerging healthcare technologies and gained foundational experience within the venture capital ecosystem. His professional background is rooted in analyzing complex scientific discoveries and determining their potential to become commercially viable biotechnology enterprises. He routinely evaluates intellectual property and broader market viability for pre-seed and seed-stage academic spinouts. Galander currently focuses on bridging the critical gap between university-led academic innovation and institutional capital to build the next generation of life science startups.